News

Johnson & Johnson completes $16.6B acquisition of medtech company | Health IT

By December 22, 2022No Comments

Johnson & Johnson has acquired medtech company Abiomed for $16.6 billion at $380 per share. Abiomed will now operate as a business unit within J&J’s medtech segment.

Health IT

Leave a Reply Cancel Reply

The Washington Metropolitan Area Chapter(WMAC) of the National Association of Health Services Executives (NAHSE) was chartered in 1978 to educate and develop minority healthcare leaders while, in conjunction with the American College of Healthcare Executives (ACHE), promoting C-Suite diversity for Healthcare Organizations throughout Northern Virginia, Southern Maryland, and the District of Columbia. The Washington Metropolitan Area Chapter (WMAC) was one of the first two chapters founded by the Association, since its inception.

Johnson & Johnson completes $16.6B acquisition of medtech company | Health IT

Tags:

Previous PostRoundup: Apollo Hospitals, Bharti Airtel conduct India's first 5G/AI guided colonoscopy and more briefs | News from healthcareitnews.com

Next Post5 recent AI healthcare updates | Health IT

Leave a Reply Cancel Reply

Join the NAHSE-WMAC Mailing List

Contact Us